{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:52:50Z","timestamp":1778539970889,"version":"3.51.4"},"reference-count":5,"publisher":"Health Affairs Publishing, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Affairs"],"published-print":{"date-parts":[[2022,9,1]]},"DOI":"10.1377\/hlthaff.2022.00119","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T15:54:10Z","timestamp":1660751650000},"page":"1273-1280","source":"Crossref","is-referenced-by-count":16,"title":["Accelerated Approval Of Cancer Drugs: No Economic Reward For Drug Makers That Conduct Confirmatory Trials"],"prefix":"10.1377","volume":"41","author":[{"given":"Richard G.","family":"Frank","sequence":"first","affiliation":[{"name":"Richard G. Frank (), Brookings Institution, Washington, D.C."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnum","family":"Shahzad","sequence":"additional","affiliation":[{"name":"Mahnum Shahzad, Harvard University, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezekiel J.","family":"Emanuel","sequence":"additional","affiliation":[{"name":"Ezekiel J. Emanuel, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"102","reference":[{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.1097"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0316"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18308"},{"issue":"80","key":"B11","first-page":"24724","volume":"77","year":"2012","journal-title":"Fed Regist"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1257\/jep.29.1.139"}],"container-title":["Health Affairs"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T15:01:50Z","timestamp":1664290910000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.2022.00119"}},"subtitle":["Study examines accelerated cancer drug trials."],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,1]]}},"alternative-id":["10.1377\/hlthaff.2022.00119"],"URL":"https:\/\/doi.org\/10.1377\/hlthaff.2022.00119","relation":{},"ISSN":["0278-2715","1544-5208"],"issn-type":[{"value":"0278-2715","type":"print"},{"value":"1544-5208","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]}}}